AU Patent

AU2001225664A1 — 5-ht3 receptor antagonists for treatment of disorders involving airway constriction

Assigned to Respiratorius AB · Expires 2001-12-24 · 24y expired

What this patent protects

Patent listed against Adasuve.

Drugs covered by this patent

Patent Metadata

Patent number
AU2001225664A1
Jurisdiction
AU
Classification
—
Expires
2001-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Respiratorius AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.